Ongoing immune, coagulation, and cardiac abnormalities are linked to increased post-discharge mortality in severely malnourished pediatric patients.

Category	Detail
Condition	Complicated Severe Malnutrition (CSM) - defined as a state of severe malnutrition requiring hospitalization.
Key Mechanisms	Persistent inflammation, endothelial dysfunction, coagulation abnormalities linked to mortality.
Target Population	HIV-negative children aged 60 days to 59 months treated for CSM, emphasizing the need for tailored interventions.
Care Setting	Hospitalized care in sub-Saharan Africa, highlighting the regional context.

High post-discharge mortality risk in severely malnourished children, with specific statistics from the study.
Persistent inflammation linked to increased mortality within 2-6 months post-discharge, supported by data.
Study conducted in four Kenyan hospitals with a focus on CSM, detailing the methodology.
Biomarkers of inflammation and coagulation were analyzed to assess mortality risk, with specific findings.
Frequency matching used to compare cases and controls effectively, ensuring robust results.

Assess malnutrition using WHO criteria (MUAC < 11.5 cm or nutritional oedema), with examples of assessment methods.
Evaluate illness severity and prior hospitalizations, providing criteria for assessment.

Implement daily co-trimoxazole prophylaxis for 6 months post-discharge, with evidence from the study.
Monitor for signs of persistent inflammation and immune dysregulation, detailing specific signs to watch for.

Follow-up monthly for 6 months, then bimonthly to 12 months, with specific goals for each follow-up.
Regular assessment of inflammatory and coagulation biomarkers, including recommended intervals.

Increased mortality associated with severe malnutrition, pneumonia, and young age, with statistical backing.
Socioeconomic disadvantage and discharge against medical advice are significant risk factors, with examples.

HIV-negative children aged 60 days to 59 months with CSM, emphasizing the need for targeted interventions.

Co-trimoxazole prophylaxis may reduce post-discharge mortality, supported by study findings.

Ensure resolution of WHO-defined danger signs before discharge, with examples of danger signs.
Educate caregivers on recognizing signs of deterioration post-discharge, providing educational resources.
Implement community-based follow-up for high-risk patients, detailing strategies for effective follow-up.

Clinical Scorecard: Ongoing immune, coagulation, and cardiac abnormalities are linked to increased post-discharge mortality in severely malnourished pediatric patients.